Temozolomide (TMZ) resistance is a significant challenge in treating glioblastoma (GBM).
Collagen remodeling has been shown to be a critical factor for therapy resistance in other cancers.
This study aimed to investigate the mechanism of TMZ chemoresistance by GBM cells reprogramming collagens.
